Abstract:Local recurrence after was the main pattern of failure for esophageal squamous cell carcinoma (ESCC) receiving definitive chemoradiotherapy. There is no ideal clinical features or blood biomarkers available to predict local recurrence of ESCC. Several studies have used CT radiomics to predict survival and treatment response of ESCC receiving chemoradiotherapy. However, little is known about the role of CT radiomics in prediction of local recurrence. We intended to establish and validate a pretreatment CT radiomics nomogram for prediction of local recurrence-free survival (LRFS) in ESCC patients receiving definite chemoradiotherapy. Three hundred eleven ESCC patients receiving IMRT or VMAT based definite chemoradiotherapy (232 in training and 79 in validation cohort) between February 2009 and June 2015 were enrolled. 2338 radiomics features were extracted from pretreatment contrast-enhanced computed tomography (CT) images of the primary tumor volume. Least absolute shrinkage and selection operator (LASSO) regression was used to select features for the radiomics signature. A radiomics nomogram was established by integrating the clinical data and radiomics signature. Nomogram discrimination and calibration were evaluated. The radiomics signature consisting of 4 selected features from contrast-enhanced CT images showed good prognostic performance in terms of predicting LRFS in two cohorts. Radiomics signature could stratify patients into high and low-risk group with different prognosis. Low-risk groups defined by radiomics signature (radscore cutoff value: -0.1152) had significant better LRFS than high-risk groups in training (p<0.001; 2-y LRFS 87.5% vs 46.6%; 3-y LRFS 82.5% vs 45.74%) and validation cohorts (p<0.05; 2-y LRFS 73.1% vs 54.4%; 3-y LRFS 73.1% vs 50.5%), respectively. Similarly, survival analysis also showed Low-risk groups defined by the same radiomics signature had significant better OS than high-risk groups in training (p<0.001; 2-y OS 69.3% vs 42%; 3-y OS 57.8% vs 35.6%) and validation cohorts (p<0.05; 2-y OS 51.9% vs 48.1%; 3-y OS 51.9% vs 33.4%), respectively. The radiomics nomogram established by integrating the radiomics signature with clinical data outperformed clinical nomogram alone (C-index in validation cohort, 0.68vs 0.624; P< 0.01). Calibration curves showed good agreement. The most optimal predictive power for evaluating LRFS could be achieved when radiomics signature was added to the clinical data. Pretreatment contrast-enhanced CT radiomics could be helpful for personalized risk stratification and treatment in ESCC patients receiving definitive chemoradiotherapy.

CT-based Radiomics Signature Analysis for Evaluation of Response to Induction Chemotherapy and Progression-Free Survival in Locally Advanced Hypopharyngeal Carcinoma

Computed Tomography-Based Radiomics Signature As a Pretreatment Predictor of Progression-Free Survival in Locally Advanced Hypopharyngeal Carcinoma with a Different Response to Induction Chemotherapy

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Radiomics Signature Based on Support Vector Machines for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.

CT radiomics nomogram predicts pathological response after induced chemotherapy and overall survival in patients with advanced laryngeal cancer: A single-center retrospective study

Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis.

Radiomics-Based Model for Pretreatment Prediction of Progression Free Survival to Hypopharyngeal Cancer with Chemoradiotherapy

Multiparametric MRI Based Radiomics for the Prediction of Induction Chemotherapy Response and Survival in Locally Advanced Nasopharyngeal Carcinoma

Discovery and Validation of a CT-Based Radiomic Signature for Preoperative Prediction of Early Recurrence in Hypopharyngeal Carcinoma

Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation

CT-Based Radiomics Nomogram May Predict Local Recurrence-free Survival in Esophageal Squamous Cell Carcinoma Patients Receiving Definitive Chemoradiotherapy: A Multicenter Study

An MRI-based radiomics-clinical nomogram for the overall survival prediction in patients with hypopharyngeal squamous cell carcinoma: a multi-cohort study

Evaluation of CT-based radiomics signature and nomogram as prognostic markers in patients with laryngeal squamous cell carcinoma

Planning CT-based Radiomics for the Prediction of Tumor Response to IMRT in Locally Advanced Cervical Cancer

Treatment Planning CT Radiomics for Predicting Treatment Outcomes and Hematologic Toxicities to Intensity-modulated Radiation Therapy in Locally Advanced Cervical Cancer

Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma

Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma

MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy

Prognostic Value of Interim CT-based Peritumoral and Intratumoral Radiomics in Laryngeal and Hypopharyngeal Cancer Patients Undergoing Definitive Radiotherapy

CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy